Sentinel lymph node biopsy with a gamma probe in patients with high-risk cutaneous squamous cell carcinoma: follow-up results of sentinel lymph node-negative patients


DEMİR H. , Isken T., Kus E., Tan Y. Z. , İŞGÖREN S. , Gorur G. , et al.

NUCLEAR MEDICINE COMMUNICATIONS, cilt.32, ss.1216-1222, 2011 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 32 Konu: 12
  • Basım Tarihi: 2011
  • Doi Numarası: 10.1097/mnm.0b013e32834b76cf
  • Dergi Adı: NUCLEAR MEDICINE COMMUNICATIONS
  • Sayfa Sayısı: ss.1216-1222

Özet

Objective Lymphoscintigraphy (LS) and sentinel lymph node biopsy have become the standard of care for melanoma and breast cancer. However, the data on patients with cutaneous squamous cell carcinoma (SCC) are limited. We aimed to evaluate and identify the role of LS and sentinel lymph node biopsy in patients with high-risk cutaneous SCC.